Ragnhild Eide Skogseth's picture

Ragnhild Eide Skogseth

Associate Professor
  • E-mailragnhild.skogseth@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease. Nature Communications.
  • Show author(s) (2024). Delirium is frequently underdiagnosed among older hospitalised patients despite available information in hospital medical records. Age and Ageing.
  • Show author(s) (2023). Inflammatory biomarkers in newly diagnosed patients with Parkinson’s disease and related neurodegenerative disorders. Neurology: Neuroimmunology and neuroinflammation.
  • Show author(s) (2019). Serum Potassium Is Associated with Cognitive Decline in Patients with Lewy Body Dementia. Journal of Alzheimer's Disease. 239-253.
  • Show author(s) (2017). Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. Journal of Alzheimer's Disease. 1139-1152.
  • Show author(s) (2015). Associations between cerebrospinal fluid biomarkers and cognition in early Untreated Parkinson's Disease. Journal of Parkinson's Disease. 783-792.
  • Show author(s) (2011). CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry. 160-164.
  • Show author(s) (2008). Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 559-563.
  • Show author(s) (2008). Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria. Dementia and Geriatric Cognitive Disorders. 445-452.
Doctoral dissertation
  • Show author(s) (2019). Biomarker and pathology studies in neurodegenerative cognitive impairment .
Academic literature review
  • Show author(s) (2016). Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 7 pages.
  • Show author(s) (2011). Biomarkører i spinalvæske ved demens. Tidsskrift for Den norske legeforening. 2235-2238.
Article in business/trade/industry journal
  • Show author(s) (2023). The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial. Frontiers in Aging Neuroscience. 10 pages.

More information in national current research information system (CRIStin)